Study on the efficacy and safety of sintilimab combined with nab-paclitaxel as second-line treatment for advanced or metastatic gastric cancer (GC)/ gastroesophageal junction (GEJ) cancer.

被引：0

作者：

Wang, Jianzheng

He, Yunduan

Zhang, Baiwen

Cheng, Xiaojiao

Li, Qingli

Lv, Huifang

Nie, Caiyun

Chen, Beibei

Xu, Weifeng

Zhao, Jing

Tu, Shuiping

Chen, Xiaobing

机构：

[1] Zhengzhou Univ, Henan Canc Hosp, Dept Gastrointestinal Med Oncol, Affiliated Canc Hosp, Zhengzhou, Peoples R China

[2] Zhengzhou Univ, Henan Canc Hosp, Dept Med Oncol, Affiliated Canc Hosp, Zhengzhou, Peoples R China

[3] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Oncol, Shanghai, Peoples R China

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e16016

引用

页码：E16016 / E16016

页数：1